SCHEMBL9669905

SCHEMBL9669905

O=Cc1ccc2c([N+](=O)[O-])cccc2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.58
▸ ALDH5A1 P51649 1/20 0.51
▸ ABAT P80404 1/20 0.51
▸ VCAM1 P19320 1/20 0.51
▸ TDP1 Q9NUW8 2/20 0.50
▸ TSHR P16473 1/20 0.47
▸ MAPT P10636 5/20 0.44
▸ ALDH3A1 P30838 2/20 0.44
▸ ALDH1A3 P47895 1/20 0.44
▸ ERN1 O75460 1/20 0.44
▸ HPGD P15428 4/20 0.43
▸ LMNA P02545 2/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ HPRT1 P00492 1/20 0.42
▸ CASP6 P55212 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ POLB P06746 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11211853 0.87 ALDH1A1 (0.58) ALDH1A1ALDH5A1ABATVCAM1TDP1
SCHEMBL9670506 0.81 TDP1 (0.62) ALDH1A1ALDH5A1ABATVCAM1TDP1
SCHEMBL9763412 0.78 ALDH1A1 (0.55) ALDH1A1TDP1TSHRMAPTERN1
SCHEMBL9735773 0.78 ALDH1A1 (0.69) ALDH1A1TDP1TSHRMAPTHPGD
SCHEMBL8668528 0.77 TSHR (0.66) ALDH1A1TDP1TSHRMAPTHPGD
SCHEMBL11284187 0.77 ERN1 (0.56) ALDH1A1TDP1TSHRMAPTERN1
SCHEMBL9734521 0.76 ALDH1A1 (0.67) ALDH1A1TDP1TSHRMAPTHPGD
SCHEMBL5784407 0.76 ALDH1A1 (0.61) ALDH1A1TDP1TSHRMAPTMEN1
SCHEMBL2934866 0.76 ALDH1A1 (0.61) ALDH1A1TDP1TSHRMAPTMEN1
SCHEMBL7835608 0.76 ALDH1A1 (0.61) ALDH1A1TDP1TSHRMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5155113-A Administering 5-fluorouracil and derivatives with pyridine and pyridone derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-10-13 — — US disclosed
EP-0180188-B1 A COMPOSITION FOR INCREASING THE ANTI-CANCER ACTIVITY OF AN ANTI-CANCER COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-04-15 — — EP disclosed
EP-0180188-A2 A composition for increasing the anti-cancer activity of an anti-cancer compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1986-05-07 — — EP disclosed
Send feedback